* Cardio Diagnostics Holdings Inc CDIO.OQ CDIO.O is
expected
to show a rise in quarterly revenue when it reports results on
March 31 (estimated) for the period ending December 31 2023
* The Chicago Illinois-based company is expected to report
a
26,215.8% increase in revenue to $250 thousand from $9.5 hundred
a year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Cardio Diagnostics
Holdings
Inc is for a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardio
Diagnostics Holdings Inc is $6.00, above its last closing
price of $1.42.
This summary was machine generated March 29 at 20:31 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)